Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 2,018 shares of Varian Medical Systems stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $111.97, for a total transaction of $225,955.46. Following the completion of the transaction, the executive vice president now directly owns 27,749 shares in the company, valued at $3,107,055.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Varian Medical Systems, Inc. (NYSE VAR) traded up $2.10 during mid-day trading on Friday, hitting $111.87. 762,726 shares of the company traded hands, compared to its average volume of 859,219. The firm has a market capitalization of $10,299.58, a PE ratio of 29.82, a P/E/G ratio of 3.30 and a beta of 0.67. Varian Medical Systems, Inc. has a twelve month low of $76.94 and a twelve month high of $114.09.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.10). The company had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The business’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.03 earnings per share. equities research analysts forecast that Varian Medical Systems, Inc. will post 4.25 EPS for the current fiscal year.

Several research firms have recently weighed in on VAR. Robert W. Baird reissued a “hold” rating and issued a $99.00 target price on shares of Varian Medical Systems in a research report on Monday, August 28th. Royal Bank of Canada set a $105.00 target price on shares of Varian Medical Systems and gave the stock a “hold” rating in a research report on Thursday, November 30th. BTIG Research downgraded shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Citigroup lifted their target price on shares of Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research report on Monday, October 30th. Finally, Zacks Investment Research downgraded shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $98.39.

Several hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in shares of Varian Medical Systems by 1.7% during the second quarter. Vanguard Group Inc. now owns 9,157,677 shares of the medical equipment provider’s stock worth $944,980,000 after purchasing an additional 150,482 shares during the period. BlackRock Inc. boosted its holdings in shares of Varian Medical Systems by 6.6% during the second quarter. BlackRock Inc. now owns 8,423,626 shares of the medical equipment provider’s stock worth $869,233,000 after purchasing an additional 523,858 shares during the period. First Eagle Investment Management LLC boosted its holdings in shares of Varian Medical Systems by 2.1% during the third quarter. First Eagle Investment Management LLC now owns 4,778,741 shares of the medical equipment provider’s stock worth $478,161,000 after purchasing an additional 99,270 shares during the period. Janus Henderson Group PLC boosted its holdings in shares of Varian Medical Systems by 1,545.7% during the second quarter. Janus Henderson Group PLC now owns 3,754,727 shares of the medical equipment provider’s stock worth $387,450,000 after purchasing an additional 3,526,571 shares during the period. Finally, Fiera Capital Corp boosted its holdings in shares of Varian Medical Systems by 12.0% during the second quarter. Fiera Capital Corp now owns 2,519,976 shares of the medical equipment provider’s stock worth $260,037,000 after purchasing an additional 269,633 shares during the period. Institutional investors and hedge funds own 99.15% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.thecerbatgem.com/2017/12/16/varian-medical-systems-inc-var-evp-kolleen-t-kennedy-sells-2018-shares.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Stock Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related stocks with our FREE daily email newsletter.